论文部分内容阅读
目的 探讨黄芪注射液 (黄芪 )对儿童支气管肺炎的治疗效果。方法 在应用抗生素的同时 ,每日采用黄芪 5、10、2 0ml三个剂量 ,并以多巴胺注射液 (多巴胺 ) 0 3～ 0 5mg/kg做对照 ,观察支气管肺炎患儿4 0 0例的疗效。结果 黄芪组痊愈显效率 82 5 0 % ,多巴胺组痊愈显效率 80 0 0 % ,前者疗效优于后者 (P <0 0 1)。黄芪组减轻咳喘平均起效时间 (2 7 6h)短于多巴胺组 (35 2h) ;黄芪组X线肺部转阴率高于多巴胺组 ;黄芪组总体降低白细胞总数的效果、CRP转阳率均优于多巴胺组。结论 黄芪是治疗儿童支气管肺炎最好的辅助药物。
Objective To investigate the therapeutic effect of astragalus injection (Astragalus) on children with bronchopneumonia. Methods At the same time of using antibiotics, the daily doses of 5, 10 and 20 ml of astragalus were used, and dopamine injection (dopamine) 0 3 ~ 0 5 mg / kg was used as the control to observe the effect of 400 cases of children with bronchopneumonia . Results Astragalus group cured markedly effective rate of 82 5 0%, dopamine group cured markedly efficient 80 0 0%, the former is better than the latter (P <0.01). Astragalus group to reduce the average onset time of asthma (276h) shorter than the dopamine group (35h); Astragalus X-ray lung metastasis rate was higher than the dopamine group; Astragalus group overall reduce the total number of leukocytes, CRP turn positive rate All better than dopamine group. Conclusion Astragalus is the best adjuvant for children with bronchopneumonia.